1073 A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of PRJ1–3024in subjects with advanced solid tumors

1073 A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of PRJ1–3024in subjects with advanced solid tumors

Bibliographic Details
Main Authors:	Yang Xu, Alexander Starodub, Cesar Perez, Yuping Li, Andrae Vandross, Jason Henry, Alexander I Spira, Xuebin Liao
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

A – 3024
by: Hans Jürgen Luibl
Published: (2005-06-01)

756 First-in-human, open-label, multicenter, phase 1 clinical study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of anti Siglec-15 PYX-106 in subjects with advanced solid tumors
by: Bin Zhang, et al.
Published: (2023-11-01)

Comparative Pharmacokinetics and Preliminary Pharmacodynamics Evaluation of Piscidin 1 Against PRV and PEDV in Rats
by: Zhixin Lei, et al.
Published: (2018-06-01)

519 A first-in-human, multicenter, phase 1/2, open-label study of XTX101 in patients with advanced solid tumors
by: John Powderly, et al.
Published: (2021-11-01)

Pharmacokinetic And Pharmacodynamic Modeling Of Mitragynine In PainTolerance
by: Ramachandram, Dinesh Sangarran
Published: (2020)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
by: White, N, et al.
Published: (1999)

Pharmacokinetics and pharmacodynamics of curcumin.
by: Sharma, R, et al.
Published: (2007)

Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
by: Mohammad Al‐Mahdi Al‐Karagholi, et al.
Published: (2021-04-01)

3024 Osteocyte-derived CXCL12 is Essential for Load-Induced Bone Formation in Adult Mice
by: Pamela Cabahug Zuckerman, et al.
Published: (2019-03-01)

Pharmacokinetic and Pharmacodynamic Characteristics of Subcutaneously Applied PTH-1-37
by: Wolf-Georg Forssmann, et al.
Published: (2016-08-01)

Renal Arterial and Venous System Variations in 1,073 Kidney Donors in Turkey
by: Abdülhak Hamit Karayağız, et al.
Published: (2021-11-01)

Fermentative Production of 1,3;1,6-β-D-Glucan (Translam), a Labeled Immunostimulant and Investigation of Its Pharmacokinetics and Pharmacodynamics
by: T. N. Zvyagintseva, et al.
Published: (2020-05-01)

Pharmacokinetic-pharmacodynamic modeling and simulation /
by: 192959 Bonate, Peter L.
Published: (2005)

Pharmacodynamics and pharmacokinetics of snake antivenom
by: Bhagya Nikapitiya, et al.
Published: (2018-06-01)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

The Pharmacokinetics and Pharmacodynamics of Iron Preparations
by: Susanna Burckhardt, et al.
Published: (2011-01-01)

Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models
by: Longfei Zhang, et al.
Published: (2022-03-01)

762 A first-in-human phase 1 clinical study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the EDB+FN targeting ADC PYX-201 in participants with advanced solid tumors
by: Bin Zhang, et al.
Published: (2023-11-01)

Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of danofloxacin in Lohi sheep
by: Z. Manzoor, et al.
Published: (2020-12-01)

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults
by: Luo Z, et al.
Published: (2025-03-01)

P1054: MYLOX-1: AN OPEN-LABEL, PHASE IIA STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR, GB2064, IN MYELOFIBROSIS
by: C. Harrison, et al.
Published: (2022-06-01)

Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling of cetagliptin in patients with type 2 diabetes mellitus
by: Chen Zhou, et al.
Published: (2024-03-01)

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.
by: White, N
Published: (1994)

Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics
by: Lees, Peter, et al.
Published: (2003)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
by: White, N, et al.
Published: (1999)

Zopiclone: some remarks on pharmacokinetics and pharmacodynamics
by: Swiss Medical Weekly
Published: (2003-02-01)

The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
by: Andrzej Czyrski, et al.
Published: (2021-11-01)

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
by: Koen G. A. M. Hussaarts, et al.
Published: (2020-08-01)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
by: Mercè Brunet, et al.
Published: (2022-08-01)

Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves
by: Jeff D. Olivarez, et al.
Published: (2023-01-01)

Pharmacokinetics and Pharmacodynamics of Anaesthetic drugs in Paediatrics
by: Rebecca Jacob, et al.
Published: (2004-01-01)

Oestrogene mimetic isoflavones’ pharmacokinetics and pharmacodynamics
by: Anca Dragomirescu,, et al.
Published: (2008-12-01)

Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds
by: Mohammad S. Alavijeh, et al.
Published: (2010-01-01)

Pharmacokinetics, Pharmacodynamics and Bioavailability of ACM‐001.1 (S‐Pindolol Benzoate) in Healthy Volunteers
by: Frank Misselwitz, et al.
Published: (2025-02-01)

Population pharmacokinetics and pharmacodynamics of nasal glucagon in patients with type 1 or 2 diabetes
by: Douglas E. James, et al.
Published: (2024-07-01)

Chromosomal Region 11p14.1 is Associated with Pharmacokinetics and Pharmacodynamics of Bisoprolol
by: Fontana V, et al.
Published: (2022-03-01)

TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)
by: Abouyannis, M, et al.
Published: (2022)

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants
by: Vidya Perera, et al.
Published: (2024-07-01)

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).
by: Ian Mcgowan, et al.
Published: (2015-01-01)

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
by: Yingying Hu, et al.
Published: (2023-08-01)